Current progress in beta-amyloid immunotherapy
- 31 October 2004
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 16 (5) , 599-606
- https://doi.org/10.1016/j.coi.2004.07.012
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based TherapeuticsAnnual Review of Pharmacology and Toxicology, 2003
- Behavioral Assessment of Alzheimer's Transgenic Mice Following Long-Term Aβ Vaccination: Task Specificity and Correlations between Aβ Deposition and Spatial MemoryDNA and Cell Biology, 2001
- Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodiesJournal of Neurochemistry, 2001
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Generation of auto-antibodies towards Alzheimer's disease vaccinationVaccine, 2001
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000
- Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseNature, 2000
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- In Vivo Reversal of Amyloid-β Lesions in Rat BrainJournal of Neuropathology and Experimental Neurology, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999